Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Rapid Dose Therapeutics Corp ( (TSE:DOSE) ) has shared an announcement.
Rapid Dose Therapeutics Corp. announced a plan for an equity private placement financing to raise up to $5 million by issuing up to 20,833,333 common shares at $0.24 each. The proceeds will be used for debt retirement, research and development, capital expansion, and working capital. The financing involves Meadowbank Asset Management Inc. as the agent, who will receive a cash commission and warrants. This move is expected to strengthen RDT’s financial position, enabling further growth and development of its innovative drug delivery solutions.
More about Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics is a Canadian biotechnology firm specializing in innovative drug delivery systems. Their flagship product, QuickStrip™, is an orally dissolvable film capable of quickly delivering a variety of active ingredients, such as nutraceuticals, pharmaceuticals, and vaccines, directly into the bloodstream.
YTD Price Performance: -17.78%
Average Trading Volume: 52,534
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$23.76M
See more data about DOSE stock on TipRanks’ Stock Analysis page.
